NSE: JYOTHYLAB | BSE: 532926

Expensive Underperformer

Download real time

334.25 -4.50 (-1.33%)

43.90% Fall from 52W High

374.3K NSE+BSE Volume

NSE 22 May, 2025 3:49 PM (IST)

12,274.1

Market Cap

Below industry Median

0.5

Beta 1Year

Very Low volatility

Jyothy Labs Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for JYOTHYLAB, BSE:532926 Jyothy Labs Ltd.

Jyothy Labs Ltd.

09 Aug 2017

334.25

-1.33%

Q1FY18 below expectations: Consolidated net sales declined 16%, while EBITDA and adj PAT plummeted 48% and 44% YoY. Volume declined 17% YoY. Management highlighted (i) wholesale destocking in general (35% of general trade), (ii) 51% sales decline in general trade in Kerala

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

08 Aug 2017

334.25

-1.33%

Jyothy Laboratories Ltd. - Result Update - 8 August 2017

Hold: Jyothy Labs Ltd.

Way2Wealth

Net sales registered a de-growth of 16% Y-O-Y to `355.9crs in Q1FY18. EBIDTA de-grew by 46% Y-O-Y to `43.6crs in the quarter. EBIDTA margins stood at 12.2% vs.19% in the same period last year. Reported PAT decline by 53% Y-O-Y to `20.6crs in Q1. PAT margins stood at 5.8%...

Sharekhan released a Economy Update report for Jyothy Labs Ltd. on 21 May, 2025.

Jyothy Labs Ltd.

04 Aug 2017

334.25

-1.33%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

ICICI Securities Limited

Jyothy Laboratories reported a disappointing set of numbers, significantly below our estimates. The pressure in the trade channel and heavy de-stocking ahead of GST implementation impacted the performance of the company. General trade, contributing 79% to the total trade channel (35% of GT is wholesale) witnessed 18% QoQ decline. Additionally, CSD had no billing for June Thus, it reported 15.0% YoY decline in net sales (volume decline of 17% YoY) to | 373.8 crore, 8.6% lower than our estimate of | 408.8...

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

04 Aug 2017

334.25

-1.33%

Jyothy Laboratories - 1QFY18 Result Update

Buy: Jyothy Labs Ltd.

Reliance Securities

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

06 Jun 2017

334.25

-1.33%

Jyothy Laboratories Ltd: Sluggish Recovery in Volumes Post D... (Jun 06, 2017)

Hold: Jyothy Labs Ltd.

Karvy

Sluggish Recovery in Volumes Post Demonetisation in Q4FY17 and Household Insecticides Yet to Improve: Jyothy Laboratories Ltd (JLL) has delivered reasonable volume growth of 5.1% in Q4FY17, compared to 13.7% volume growth in Q4FY16. The company hasreported total income from operations at Rs.4661 Mn during this quarter, clocking 3.8% growth YoY compared to Rs.4490 Mn in Q4FY16. The companys EBITDAmargins improved QoQ by 29 bps to reach 13.0% during the quarter compared to 12.7% during Q3FY17 on the back of reduction in employee cost.

Jyothy Labs Ltd. has an average target of 453.75 from 5 brokers.

Jyothy Labs Ltd.

25 May 2017

334.25

-1.33%

Result Update:Jyothy Lab.

Hold: Jyothy Labs Ltd.

Axis Direct

Net sales, EBITDA and Adj PAT grew 4%, -4% and 35%. Overall volumes grew 5.1% but ex-HI, the growth was higher at9.7%.Personal wash and fabric care posted decent growth of 23% and 8% (given higher share of south). Dish wash recorded muted sales growth at 4%.

Sharekhan released a Economy Update report for Jyothy Labs Ltd. on 21 May, 2025.

Jyothy Labs Ltd.

24 May 2017

334.25

-1.33%

Jyothy Labs

Hold: Jyothy Labs Ltd.

Geojit BNP Paribas

JLL's revenue grew at muted 4%YoY in Q4FY17 impacted by demonetisation and muted price growth. EBITDA margins contracted 90bps YoY due to 190bps YoY reduction in gross margins on muted price growth. We reduce our FY18E revenue forecasts by 5% factoring the demonetisation, while we expect revival in demand will drive revenue to grow at 11% CAGR over FY17-19E. EBITDA margins will face medium term headwinds, but once price...

Jyothy Labs Ltd. is trading below all available SMAs

Jyothy Labs Ltd.

23 May 2017

334.25

-1.33%

Jyothy Laboratories Ltd. - Result Update - 23 May 2017

Hold: Jyothy Labs Ltd.

Way2Wealth

Backed by volume growth of 5.1%& 6.9% in Q4 and FY17 respectively, the company clocked a 4.1%& 5.5% growth in its Net Sales for the same time periods. Power brands recorded a growth of 2.6% driven by volume growth of 4.1% in Q4. For FY17 power...

Number of FII/FPI investors decreased from 224 to 215 in Mar 2025 qtr

Jyothy Labs Ltd.

22 May 2017, 12:00AM

334.25

-1.33%

Jyothy Laboratories

Hold: Jyothy Labs Ltd.

ICICI Securities Limited

Fabric care and dishwashing segment grew 8.9% and 4.2% YoY to | 180.2 crore and | 120.9 crore, respectively. However, household insecticide continued to report a decline in revenue. It declined 6.5% YoY. Personal care segment grew 22.5% YoY on a small base EBITDA remained flat for the quarter at | 62.7 crore (I-direct estimate: | 64 crore). Raw material cost as a percentage of net sales grew 200 bps YoY led by a rise in input cost, thus, operating profit contracted marginally by 53 bps YoY to 13.9% against our estimate of 14.4%...

Jyothy Labs Ltd. is trading below all available SMAs

Is Jyothy Labs Ltd. worth buying?

280 Votes:

Buy 80.71%

Sell 11.43%

Hold 7.86%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Neutral SEE REPORTS >

pdf